Today's Low
₹ 328.50
Today's High
₹ 335.70
52 Weeks Low
₹ 306.40
52 Weeks High
₹ 423.90
Lower
₹ 265.50
Upper
₹ 398.20
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 808.2 | 866.9 | 622.5 | 563.1 | 538.1 | 539.0 | 572.0 | 464.5 | 385.4 | 304.6 | 275.5 | 166.3 |
Total Non-Current Assets | 905.5 | 712.5 | 711.8 | 676.5 | 684.5 | 678.7 | 616.7 | 481.2 | 460.2 | 424.9 | 416.4 | 143.5 |
Total Assets | 1,713.7 | 1,579.4 | 1,334.3 | 1,239.6 | 1,222.5 | 1,217.7 | 1,188.8 | 945.8 | 845.6 | 729.4 | 691.9 | 310.7 |
Total Current Liabilities | 424.5 | 518.2 | 406.9 | 459.0 | 445.5 | 417.4 | 390.4 | 303.0 | 262.1 | 202.2 | 199.3 | 58.5 |
Total Non-Current Liabilities | 260.9 | 156.6 | 158.4 | 101.0 | 116.4 | 125.3 | 147.0 | 66.3 | 64.7 | 69.9 | 78.2 | 53.8 |
Shareholder's Funds | 1,028.3 | 904.6 | 769.0 | 679.6 | 660.6 | 675.0 | 651.3 | 576.5 | 518.8 | 457.2 | 414.2 | 198.4 |
Total Liabilities | 1,713.7 | 1,579.4 | 1,334.3 | 1,239.6 | 1,222.5 | 1,217.7 | 1,188.8 | 945.8 | 845.6 | 729.4 | 691.9 | 310.7 |
The Industry Debt to Equity Ratio stands at 0.22, vs the Debt to Equity Ratio of 0.39, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 0.77, which results in a Negative aspect.
The Industry Current Ratio stands at 2.31, vs the Current Ratio of 1.23, which results in a Negative aspect.
The Industry Price to BV stands at 6.08, vs the Price to BV of 2.83, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 1,668.6 | 1,540.8 | 1,241.5 | 1,106.6 | 968.5 | 1,041.9 | 1,074.8 | 1,008.1 | 857.3 | 732.6 | 630.8 | 243.4 |
Total Expenditure | 1,382.6 | 1,214.5 | 1,023.2 | 985.7 | 891.8 | 910.4 | 920.3 | 840.2 | 691.8 | 614.4 | 538.2 | 198.4 |
Operating Profit(Excl OI) | 288.4 | 329.7 | 227.4 | 125.6 | 83.4 | 139.6 | 160.4 | 172.0 | 167.2 | 122.1 | 94.1 | 55.1 |
Add: Other Income | 2.4 | 3.4 | 9.1 | 4.8 | 6.7 | 8.1 | 5.9 | 4.0 | 1.7 | 4.0 | 1.5 | 10.0 |
Operating Profit | 288.4 | 329.7 | 227.4 | 125.6 | 83.4 | 139.6 | 160.4 | 172.0 | 167.2 | 122.1 | 94.1 | 55.1 |
Less: Interest | 25.0 | 14.1 | 22.3 | 26.3 | 21.1 | 23.5 | 6.2 | 12.4 | 10.6 | 18.9 | 21.9 | 5.8 |
PBDT | 263.4 | 315.5 | 205.1 | 99.4 | 62.3 | 116.1 | 154.2 | 159.6 | 156.6 | 103.2 | 72.3 | 49.3 |
Less: Depreciation Amortization | 70.6 | 79.0 | 73.1 | 70.8 | 71.6 | 67.7 | 63.3 | 60.7 | 47.1 | 30.9 | 23.7 | 6.3 |
PBT & Exceptional Items | 192.8 | 236.6 | 132.0 | 28.6 | -9.3 | 48.4 | 90.9 | 98.9 | 109.6 | 72.3 | 48.6 | 43.0 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 192.8 | 236.6 | 132.0 | 28.6 | -9.3 | 48.4 | 90.9 | 98.9 | 109.6 | 72.3 | 48.6 | 43.0 |
Less: Taxation | 50.5 | 81.8 | 39.0 | 4.5 | -6.4 | 7.2 | 13.9 | 17.0 | 26.7 | 14.3 | 5.8 | 11.5 |
Profit After Tax | 142.3 | 154.8 | 93.1 | 24.1 | -2.9 | 41.2 | 77.1 | 81.9 | 82.8 | 58.0 | 42.8 | 31.5 |
Earnings Per Share | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
The Industry Dividend Yield stands at 0.59, vs the Dividend Yield of 0.68, which results in a Positive aspect.
The Industry PAT Margin stands at 9.73, vs the PAT Margin of 2.18, which results in a Negative aspect.
The Industry PAT Growth stands at 32.10, vs the PAT Growth of 930.49, which results in a Positive aspect.
The Industry PE Ratio stands at 43.11, vs the PE Ratio of 30.17, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 192.8 | 236.6 | 132.0 | 28.6 | -9.3 | 48.4 | 90.9 | 98.9 | 109.5 | 72.3 | 48.6 | 43.0 |
Tax Paid | -61.7 | -41.1 | -19.7 | -3.8 | -3.5 | -10.1 | -23.7 | -27.4 | -24.7 | -14.7 | -8.4 | -6.7 |
Adjustment | 120.9 | 87.1 | 109.8 | 99.5 | 89.4 | 97.7 | 64.6 | 79.2 | 65.2 | 50.4 | 47.1 | 6.8 |
Changes In Working Capital | 192.8 | 236.6 | 132.0 | 28.6 | -9.3 | 48.4 | 90.9 | 98.9 | 109.5 | 72.3 | 48.6 | 43.0 |
Cash Flow after changes in Working Capital | 240.5 | 214.9 | 101.9 | 126.6 | 135.7 | 132.8 | 112.3 | 139.6 | 133.7 | 113.5 | 77.1 | 43.7 |
Cash Flow from Operating Activities | 178.8 | 173.8 | 82.2 | 122.8 | 132.1 | 122.7 | 88.6 | 112.2 | 109.0 | 98.8 | 68.7 | 37.0 |
Cash Flow from Investing Activities | -208.2 | -121.4 | -66.7 | -55.9 | -103.8 | -135.4 | -170.6 | -110.7 | -88.4 | -41.0 | -42.6 | -15.8 |
Cash Flow from Financing Activities | 22.8 | -44.4 | -29.9 | -63.9 | -16.1 | -38.8 | 131.6 | -1.6 | -19.9 | -59.0 | -24.4 | -24.6 |
Net Cash Inflow / Outflow | -6.5 | 8.0 | -14.3 | 3.0 | 12.2 | -51.5 | 49.7 | -0.1 | 0.7 | -1.2 | 1.7 | -3.4 |
Opening Cash & Cash Equivalents | 17.5 | 9.4 | 23.8 | 20.8 | 8.6 | 60.1 | 10.4 | 10.5 | 9.8 | 10.9 | 9.2 | 28.6 |
Closing Cash & Cash Equivalent | 10.9 | 17.5 | 9.4 | 23.8 | 20.8 | 8.6 | 60.1 | 10.4 | 10.5 | 9.8 | 10.9 | 25.2 |
The Industry PFCF Ratio stands at 25.12, vs the PFCF Ratio of 55.15, which results in a Positive aspect.
The Industry PCF RATIO stands at 24.27, vs the PCF RATIO of 15.70, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 4,594.2 | 4,817.3 | 4,265.0 | 4,281.6 | 3,992.0 | 4,330.4 | 4,082.2 | 4,091.3 | 3,580.0 | 3,868.7 | 3,867.5 | 3,051.4 | 3,322.9 | 3,282.4 | 2,758.6 | 2,719.9 |
Total Income | 4,617.7 | 4,861.6 | 4,269.1 | 4,286.6 | 3,995.6 | 4,333.9 | 4,093.5 | 4,094.3 | 3,581.6 | 3,878.8 | 3,876.1 | 3,071.2 | 3,326.5 | 3,287.6 | 2,761.2 | 2,724.9 |
Total Expenditure | 3,965.2 | 4,103.6 | 3,653.3 | 3,634.0 | 3,371.6 | 3,451.9 | 3,367.7 | 3,285.9 | 2,845.5 | 3,004.3 | 2,998.5 | 2,504.2 | 2,721.1 | 2,675.2 | 2,272.1 | 2,387.0 |
PBIDT (Excl OI) | 629.0 | 713.7 | 611.7 | 647.6 | 620.4 | 878.5 | 714.5 | 805.4 | 734.5 | 864.4 | 869.0 | 547.2 | 601.8 | 607.2 | 486.5 | 332.9 |
Other Income | 23.5 | 44.3 | 4.1 | 5.0 | 3.6 | 3.5 | 11.3 | 3.0 | 1.6 | 10.1 | 8.6 | 19.8 | 3.6 | 5.2 | 2.6 | 5.0 |
Operating Profit | 652.5 | 758.0 | 615.8 | 652.6 | 624.0 | 882.0 | 725.8 | 808.4 | 736.1 | 874.5 | 877.6 | 567.0 | 605.4 | 612.4 | 489.1 | 337.9 |
Interest | 100.7 | 81.1 | 77.9 | 86.4 | 70.1 | 52.5 | 41.3 | 30.4 | 38.1 | 30.5 | 42.4 | 45.9 | 60.3 | 58.9 | 57.5 | 78.3 |
Exceptional Items | -82.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 469.8 | 676.9 | 537.9 | 566.2 | 553.9 | 829.5 | 684.5 | 778.0 | 698.0 | 844.0 | 835.2 | 521.1 | 545.1 | 553.5 | 431.6 | 259.6 |
Depreciation | 243.5 | 214.1 | 198.8 | 176.9 | 171.7 | 156.5 | 201.0 | 180.5 | 192.2 | 194.5 | 222.3 | 185.5 | 168.8 | 185.7 | 191.3 | 182.0 |
Profit Before Tax | 226.3 | 462.8 | 339.1 | 389.3 | 382.2 | 673.0 | 483.5 | 597.5 | 505.8 | 649.5 | 612.9 | 335.6 | 376.3 | 367.8 | 240.3 | 77.6 |
Tax | 70.7 | 110.4 | 97.3 | 131.2 | 100.7 | 175.7 | 97.8 | 193.0 | 175.9 | 232.6 | 216.3 | 85.6 | 122.7 | 111.3 | 69.9 | 24.0 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 155.6 | 352.4 | 241.8 | 258.1 | 281.5 | 497.3 | 385.7 | 404.5 | 329.9 | 416.9 | 396.6 | 250.0 | 253.6 | 256.5 | 170.4 | 53.6 |
Net Profit | 155.6 | 352.4 | 241.8 | 258.1 | 281.5 | 497.3 | 385.7 | 404.5 | 329.9 | 416.9 | 396.6 | 250.0 | 253.6 | 256.5 | 170.4 | 53.6 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 | 184.3 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 1.7 | 3.8 | 2.6 | 2.8 | 3.1 | 5.4 | 4.2 | 4.4 | 3.6 | 4.5 | 4.3 | 2.7 | 2.8 | 2.8 | 1.9 | 0.6 |
Operating Profit Margin | 14.2 | 15.7 | 14.4 | 15.2 | 15.6 | 20.4 | 17.8 | 19.8 | 20.6 | 22.6 | 22.7 | 18.6 | 18.2 | 18.7 | 17.7 | 12.4 |
Net Profit Margin | 3.4 | 7.3 | 5.7 | 6.0 | 7.1 | 11.5 | 9.4 | 9.9 | 9.2 | 10.8 | 10.3 | 8.2 | 7.6 | 7.8 | 6.2 | 2.0 |
The Industry Net Sales Growth stands at 11.07, vs the Net Sales Growth of 14.26, which results in a Positive aspect.
The Industry Mcap Growth stands at 19.65, vs the Mcap Growth of 3.28, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 345.30 | 353.10 | 334.86 |
R3 | 342.10 | 341.70 | 332.88 |
R2 | 338.90 | 338.70 | 332.22 |
R1 | 334.90 | 334.50 | 331.56 |
Pivot | 331.70 | 331.50 | 331.70 |
S1 | 327.70 | 327.30 | 330.24 |
S2 | 324.50 | 324.30 | 329.58 |
S3 | 320.50 | 320.10 | 328.92 |
S4 | 316.50 | 309.90 | 326.94 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
23.14
Neutral
RSI
38.33
Neutral
ROC
-2.66
Bearish
UltimateOscillator
34.96
Neutral
Williams Indicator
-92.26
Bullish
CCI Indicator
-97.03
Neutral
MACD
-2,677.93
Bearish
Stochastic Indicator
8.45
Neutral
ATR
11.85
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
18-09-2023 | 2.25 | 112.5 | Final |
14-09-2022 | 1.50 | 75 | Final |
14-09-2022 | 0.75 | 37.5 | Special |
17-09-2021 | 1.50 | 75 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
23-01-2024 | Quarterly Results |
19-10-2023 | Quarterly Results |
25-07-2023 | Quarterly Results |
23-05-2023 | Final Dividend & Audited Results |
24-01-2023 | Quarterly Results |
10-11-2022 | Quarterly Results |
09-08-2022 | Quarterly Results |
17-05-2022 | Audited Results & Final Dividend |
01-02-2022 | Quarterly Results |
02-11-2021 | Quarterly Results |
11-08-2021 | Quarterly Results |